Margaret A. Hamburg, MD, the second woman nominated to be commissioner of the Food and Drug Administration (FDA), stepped down from the post in late March, just shy of 6 years on the job.
The agency’s responsibilities grew within weeks of Hamburg assuming the post, when President Obama signed a law allowing the FDA to regulate tobacco products. The speed of approvals quickened during her tenure, with the FDA greenlighting 51 novel drugs and biologics in 2014, the most in almost 20 years, Hamburg wrote in a blog post February 5 (http://1.usa.gov/19GXDeu). Among the drugs approved in 2014 were 4 novel systemic antibiotics, only 1 less than the number approved the entire previous decade, she wrote.
Rubin R. Margaret A. Hamburg, MD, Reflects on 6 Years at FDA. JAMA. 2015;313(23):2309-2310. doi:10.1001/jama.2015.3911